Active implantable medical device with cardiac lead and peripheral lead discrimination

US2016136445A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2016136445-A1
Application numberUS-201514945171-A
CountryUS
Kind codeA1
Filing dateNov 18, 2015
Priority dateNov 19, 2014
Publication dateMay 19, 2016
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The device includes a cardiac therapy circuit with a first terminal, and a peripheral therapy circuit with a second terminal. These terminals can either receive a cardiac detection/stimulation lead or a peripheral detection/stimulation lead of an organ. The device is configured to recognize the leads and automatically configure the connection terminals according to the type of lead received by the terminal. This includes discrimination methods for identifying the terminal on which a cardiac signal is detected, and selectively activating the cardiac therapy circuit and the peripheral therapy circuit based on the detection of the cardiac signal on a lead.

First claim

Opening claim text (preview).

What is claimed is: 1 . An active implantable medical device comprising: a cardiac therapy circuit configured to generate stimulation, defibrillation and/or resynchronization pulses; a peripheral therapy circuit configured to generate peripheral stimulation pulses; first and second connection terminals, each adapted to receive either a first lead or a second lead, wherein the first connection terminal is coupled to the cardiac therapy circuit and the second connection terminal is coupled to the peripheral therapy circuit; wherein one of the leads is a cardiac detection/stimulation lead and the other is a peripheral detection/stimulation lead; a processor configured to verify a respective connection configuration of the leads to the first and second connection terminals and selectively activate or inhibit the cardiac and peripheral therapy circuits by: collecting a signal on the first connection terminal; analyzing the signal to detect whether a cardiac signal is present; selectively activating the cardiac therapy circuit and peripheral therapy circuit when the presence of the cardiac signal is detected on the first connection terminal; and selectively inhibiting the cardiac therapy circuit and peripheral therapy circuit when the presence of a cardiac signal is not detected on the first connection terminal. 2 . The device of claim 1 , wherein the processor is further configured to emit an alert signal when the cardiac therapy circuit and the peripheral therapy circuit are inhibited. 3 . The device of claim 1 , wherein the processor is further configured to emit a confirmation signal when the cardiac therapy circuit and the peripheral therapy circuit are activated. 4 . The device of claim 1 , wherein the processor is further configured to conduct a level test by collecting signals on the first and second connection terminals during a predetermined detection window, wherein the level test comprises detecting whether a cardiac signal is present on the terminal when a level of the signal on the corresponding terminal exceeds a given threshold. 5 . The device of claim 4 , wherein the level test further comprises a stability test evaluating a plurality of intervals between successive events of the signal collected during the duration of the predetermined detection window when a cardiac signal is present, wherein the stability test outputs an indicator of stability or absence of stability; and the processor is further configured to supply an inhibition command to the cardiac therapy and peripheral therapy circuits when the indicator is an indicator of absence of stability. 6 . The device of claim 4 , wherein the processor is further configured to: conduct a level comparison, wherein the level comparison is a calculation of a difference between the levels of the signals respectively collected on the first and second terminals detected by the level test; couple the cardiac therapy circuit to the connection terminal wherein a high signal level was collected; and couple the peripheral therapy circuit to the connection terminal wherein a low signal level was collected. 7 . A medical device comprising: a cardiac therapy circuit configured to generate stimulation, defibrillation and/or resynchronization pulses; a peripheral therapy circuit configured to generate peripheral stimulation pulses; first and second connection terminals, each adapted to receive either a first lead or a second lead, wherein the first connection terminal is coupled to the cardiac therapy circuit and the second connection terminal is coupled to the peripheral therapy circuit; wherein one of the leads is a cardiac detection/stimulation lead and the other is a peripheral detection/stimulation lead; a processor configured to verify a respective connection configuration of the leads to the first and second connection terminals and selectively activate or inhibit the cardiac and peripheral therapy circuits by: collecting a signal on the first connection terminal; analyzing the signal to detect whether a cardiac signal is present; collecting a second signal on the second connection terminal; analyzing the second signal to detect whether a cardiac signal is present; selectively activating the cardiac therapy circuit and peripheral therapy circuit when the presence of the cardiac signal is detected on the first connection terminal and the presence of a cardiac signal is not detected on the second connection terminal; and selectively inhibiting the cardiac therapy circuit and peripheral therapy circuit when at least one of the following occurs: the presence of a cardiac signal is not detected on the first connection terminal or the presence of the cardiac signal is detected on the second connection terminal. 8 . The device of claim 7 , wherein the processor is further configured to emit an alert signal when the cardiac therapy circuit and the peripheral therapy circuit are inhibited. 9 . The device of claim 7 , wherein the processor is further configured to emit a confirmation signal when the cardiac therapy circuit and the peripheral therapy circuit are activated. 10 . The device of claim 7 , wherein the processor is further configured to conduct a level test by collecting signals on the first and second connection terminals during a predetermined detection window, wherein the level test comprises detecting whether a cardiac signal is present on the terminal when a level of the signal on the corresponding terminal exceeds a given threshold. 11 . The device of claim 10 , wherein the level test further comprises a stability test evaluating a plurality of intervals between successive events of the signal collected during the duration of the predetermined detection window when a cardiac signal is present, wherein the stability test outputs an indicator of stability or absence of stability; and the processor is further configured to supply an inhibition command to the cardiac therapy and peripheral therapy circuits when the indicator is an indicator of absence of stability. 12 . The device of claim 10 , wherein the processor is further configured to: conduct a level comparison, wherein the level comparison is a calculation of a difference between the levels of the signals respectively collected on the first and second terminals detected by the level test; couple the cardiac therapy circuit to the connection terminal wherein a high signal level was collected; and couple the peripheral therapy circuit to the connection terminal wherein a low signal level was collected. 13 . A method of discriminating between and activating a plurality of leads, the method comprising: verifying a terminal connection configuration of the plurality of leads to a first and a second connection terminals, wherein the terminal connection configuration is verified by: collecting a signal on the first connection terminal; analyzing the signal to detect whether a cardiac signal is present; collecting a second signal on the second connection terminal; and analyzing the second signal to detect whether a cardiac signal is present; selectively activating a cardiac therapy circuit and peripheral therapy circuit when the presence of a cardiac signal is detected on the first connection terminal and the presence of a cardiac signal is not detected on the second connection terminal; and selectively inhibiting the cardiac therapy circuit and peripheral therapy circuit when at least one of the following occurs: the presence of a cardiac signal is not detected on the first connection terminal and the presence of a cardiac signal is detected on the second connection terminal.

Assignees

Inventors

Classifications

  • A61N1/3605Primary

    Implantable neurostimulators for stimulating central or peripheral nerve system · CPC title

  • Physiological parameters (A61N1/365 takes precedence; evoked response A61N1/371) · CPC title

  • Spinal or peripheral nerve electrodes · CPC title

  • configured for selecting the electrode configuration on a lead (A61N1/3688 takes precedence) · CPC title

  • Monitoring; Protecting · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2016136445A1 cover?
The device includes a cardiac therapy circuit with a first terminal, and a peripheral therapy circuit with a second terminal. These terminals can either receive a cardiac detection/stimulation lead or a peripheral detection/stimulation lead of an organ. The device is configured to recognize the leads and automatically configure the connection terminals according to the type of lead received by …
Who is the assignee on this patent?
Sorin Crm Sas
What technology area does this patent fall under?
Primary CPC classification A61N1/3605. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Thu May 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).